Search Results

Perosphere Technologies today announced Michael A. Grosso, MD, FACS, joins its Advisory Board.

Perosphere Technologies, a private medical technologies company focused on developing next-generation coagulation diagnostics, announced the appointment of Michelle Brennan to its Board of Directors.

Perosphere Technologies has announced the receipt of two prestigious federal grants: a Direct Phase II Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, and a subaward through an Atlanta Center for Microsystems Engineered Point-of-Care Technologies Center Grant, funded by the National Institute of Biomedical Imaging and Bioengineering.

We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system

Perosphere Technologies Inc. today announced CE (Conformité Européene)-IVD Marking of its Point-of-Care (PoC) Coagulometer System.

Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).

Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).

Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”).

Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.

Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.